MDCX

Dopo l'orario di chiusura: .45 0.003 +0.67%

Medicus Pharma Ltd (MDCX)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Medicus Pharma Ltd Stock (MDCX) Company Profile

Medicus Pharma Ltd

Healthcare (1118)

610-540-7515

300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN

Prossima data di guadagno

Ultimi documenti SEC

MDCX's Discussions on Twitter

Compare MDCX vs LLY, JNJ, ABBV, AZN, MRK

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MDCX Medicus Pharma Ltd	0.447	13.29M	0	-27.04M	-17.53M	-1.9743
LLY Lilly Eli Co	935.58	835.81B	65.18B	20.64B	5.96B	22.59
JNJ Johnson Johnson	243.04	585.39B	94.19B	26.80B	19.70B	11.05
ABBV Abbvie Inc	208.84	369.39B	61.16B	4.19B	17.82B	2.3614
AZN Astrazeneca Plc	203.49	315.58B	58.80B	10.24B	8.98B	3.2788
MRK Merck Co Inc	120.87	298.84B	64.93B	18.26B	12.36B	7.2751

Medicus Pharma Ltd Borsa (MDCX) Ultime notizie

Medicus Pharma Ltd Azioni (MDCX) Dati Finanziari

Medicus Pharma Ltd (MDCX)

Medicus Pharma Ltd Stock (MDCX) Company Profile

Compare MDCX vs LLY, JNJ, ABBV, AZN, MRK

Medicus Pharma Ltd Borsa (MDCX) Ultime notizie

Medicus Pharma SkinJect Phase 2 study data endorsed by independent expertICYMI - Proactive financial news

Medicus Pharma Marks Nasdaq Anniversary With Opening Bell Ceremony - gosanangelo.com

Medicus Pharma stock swings after skin cancer treatment results - MSN

Medicus Pharma on Bloomberg World - Bluffton Today

Medicus Pharma Ltd. (MDCX) stock price, news, quote and history - Yahoo Finance Singapore

Medicus Pharma clarifies Phase 2 skin cancer study results By Investing.com - Investing.com South Africa

MDCX SEC FilingsMedicus Pharma Ltd 10-K, 10-Q, 8-K Forms - Stock Titan

MDCX Forecast, Price Target & Analyst Ratings | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill

Medicus Pharma (MDCX) COO granted 50,000 options at $0.50 exercise price - Stock Titan

Director at Medicus Pharma (NASDAQ: MDCX) awarded 25,000 stock options at $0.50 - Stock Titan

Director at Medicus Pharma (NASDAQ: MDCX) receives 25,000 stock options at $0.50 strike - Stock Titan

CMO at Medicus Pharma (MDCX) receives 125,000 stock options grant - Stock Titan

[Form 4] Medicus Pharma Ltd. Insider Trading Activity - Stock Titan

Medicus Pharma (MDCX) director granted stock options for 25,000 Common Shares - Stock Titan

Director Barry Fishman granted 25,000 Medicus Pharma (MDCX) stock options - Stock Titan

Medicus Pharma (MDCX) grants director 25K stock options at $0.50 - Stock Titan

Medicus Pharma (MDCX) Chief Scientific Officer receives 25,000 stock options grant - Stock Titan

Medicus Pharma (MDCX) grants CFO 100,000 stock options - Stock Titan

Medicus Pharma (NASDAQ: MDCX) CEO awarded 325,000 options at $0.50 strike - Stock Titan

Medicus Pharma (NASDAQ: MDCX) director receives grant of 25,000 options at $0.50 strike - Stock Titan

Medicus Pharma eyes registrational study for SkinJect after positive Phase 2 data - Yahoo Finance

Medicus Pharma Ltd clarifies positive Skinject phase 2 dataset - MarketScreener

Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset - The Manila Times

Medicus Pharma clarifies Phase 2 skin cancer study results - Investing.com

Skin cancer study points to stronger results at higher SkinJect dose - Stock Titan

MDCXW Financials: Income Statement, Balance Sheet & Cash Flow | Medicus Pharma Ltd - Stock Titan

MDCX Stock Price, Quote & Chart | MEDICUS PHARMA LTD (NASDAQ:MDCX) - ChartMill

Ideas Watch: Is Medicus Pharma Ltd Equity Warrant likely to announce a buybackQuarterly Portfolio Summary & Accurate Trade Setup Notifications - baoquankhu1.vn

Small cap wrap: Namibia Critical Metals, Medicus Pharma, Greatland Resources... - Proactive financial news

Medicus Pharma’s SkinJect Phase 2 Data Validated by KOL With 80% Response Rate - tipranks.com

Medicus Pharma’s SkinJect Data Earns KOL Validation With 80% Response in Phase 2 - tipranks.com

D. Boral Capital cuts Medicus Pharma stock price target on dilution concerns - ca.investing.com

Medicus Pharma highlights independent support for Phase 2 SkinJect results - Yahoo! Finance Canada

Medicus Pharma Ltd Reports KOL Validation of Skinject Phase 2 Data of 80% Overall Response Rate - MarketScreener

Medicus Pharma reports Kol validation of Skinject phase 2 data of 80% overall response rate - MarketScreener

Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate - Caledonian Record

[EFFECT] Medicus Pharma Ltd. SEC Filing - Stock Titan

Bull Bear: Is Medicus Pharma Ltd Equity Warrant stock forming a cup and handleMarket Risk Report & Momentum Based Trading Ideas - baoquankhu1.vn

Free cash flow per share of Medicus Pharma Ltd. – NASDAQ:MDCXW - TradingView

Medicus Pharma (MDCX): A Small-Cap Biotech Making Moves in 2026 - openPR.com

Medicus Pharma reports 80% response rate in skin cancer study By Investing.com - Investing.com South Africa

Medicus Pharma to host business update call featuring clinical investigator - MSN

Medicus Pharma Highlights Strong SkinJect Phase 2 Results and AI-Driven Development Plan - TipRanks

Medicus Pharma advances SkinJect, Teverelix programs, eyes catalyst-rich 2026 - Yahoo Finance

Medicus Pharma reports 80% response rate in skin cancer study - Investing.com

Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan - The Manila Times

Medicus Pharma Ltd Azioni (MDCX) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a MDCX